Empire Financial Management Company’s AbbVie ABBV Stock Holding History

Empire Financial Management Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.35M	Sell	25,222 -4,247	-14%	-$914K	2.51%	6
2026 Q1	$6.41M	Buy	29,469 +988	+3%	+$219K	1.45%	13
2025 Q4	$6.51M	Buy	28,481 +44	+0.2%	+$10K	1.41%	13
2025 Q3	$6.58M	Buy	28,437 +686	+2%	+$140K	1.51%	11
2025 Q2	$5.15M	Buy	27,751 +628	+2%	+$117K	1.49%	13
2025 Q1	$5.68M	Sell	27,123 -1,076	-4%	-$209K	1.76%	8
2024 Q4	$5.01M	Buy	28,199 +16,329	+138%	+$3M	1.56%	9
2024 Q3	$2.34M	Sell	11,870 -100	-0.8%	-$18.7K	0.72%	44
2024 Q2	$2.05M	Sell	11,970 -1,092	-8%	-$181K	0.68%	47
2024 Q1	$2.38M	Buy	13,062 +4,992	+62%	+$860K	0.79%	36
2023 Q4	$1.25M	Buy	8,070 +33	+0.4%	+$4.81K	0.49%	62
2023 Q3	$1.2M	Sell	8,037 -6,740	-46%	-$989K	0.52%	58
2023 Q2	$1.99M	Sell	14,777 -1,582	-10%	-$232K	0.79%	38
2023 Q1	$2.61M	Buy	+16,359	New	+$2.5M	1.06%	29

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Empire Financial Management Company's ABBV Position: Q2 2026 in Review

Empire Financial Management Company reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $914K and leaving 25,222 shares worth $6.35M. The position accounts for 2.51% of the portfolio, ranked #6.

Empire Financial Management Company first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.58M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Empire Financial Management Company held 25,222 shares of AbbVie worth $6.35M as of Q2 2026.
Empire Financial Management Company sold 4,247 AbbVie shares in Q2 2026, an estimated $914K.
AbbVie made up 2.51% of Empire Financial Management Company's portfolio in Q2 2026, its #6 holding.
Empire Financial Management Company first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
Empire Financial Management Company's AbbVie position peaked at $6.58M in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Empire Financial Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.